Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer.
about
Immunotherapy and Targeted Therapy for Small Cell Lung Cancer: There Is Hope.Found in Translation: How Preclinical Research Is Guiding the Clinical Development of the BCL2-Selective Inhibitor Venetoclax.Second-line treatments of small-cell lung cancers.Oncosuppressors and Oncogenes: Role in Haemangioma Genesis and Potential for Therapeutic Targeting.Synergistic anti-proliferative effects of combination of ABT-263 and MCL-1 selective inhibitor A-1210477 on cervical cancer cell lines.BH3 mimetics induce apoptosis independent of DRP-1 in melanoma
P2860
Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Combination with vorinostat ov ...... nce of small cell lung cancer.
@en
type
label
Combination with vorinostat ov ...... nce of small cell lung cancer.
@en
prefLabel
Combination with vorinostat ov ...... nce of small cell lung cancer.
@en
P2093
P2860
P1476
Combination with vorinostat ov ...... nce of small cell lung cancer.
@en
P2093
Geoffrey W Krystal
Hisashi Harada
Kanika Sharma
Mark A Hicks
Rikiara Brown
Wataru Nakajima
P2860
P356
10.1080/15384047.2015.1108485
P577
2015-11-17T00:00:00Z